Last Updated on October 15, 2024 by The Health Master
Glenmark Pharma has received final approval by the US Food and Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytiga Tablets, 500 mg, of Janssen Biotech, the company informed via a statement.
According to IQVIA sales data for the 12-month period ending March 2022, the Zytiga tablets, 500 mg market achieved annual sales of approximately $260.2 million.
USFDA approves Oral Form for the treatment of Amyotrophic lateral sclerosis (ALS)
USFDA gives nod to Sun Pharma Mesalamine extended release capsules
USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution
USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam
USFDA gives tentative approval for this Hypertension drug
USFDA gives tentative nod to Zydus for Selexipag tablets
Govt amends Rules to add suspension and cancellation of license provisions…
CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure
USFDA completes inspection of Aurobindo Pharma with no remaining deficiencies
Regulatory framework for Nutraceutical
Govt preparing roadmap for strengthening testing infrastructure for Medical Devices
Govt: Conduct due diligence on claims of local manufacturers of 67 Drugs
USFDA-Gujarat FDCA Regulatory Forum to be held from 17th to 19th May
Lupin, Glenmark, Dr Reddys recall these BP drugs
FAQs – on Schedule-P (Expiry Date of drugs)
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
